• Simvastatin (Zocor) in Advanced Cancer and Lipid Research Wo

  2026-05-18

  Simvastatin (Zocor) from APExBIO stands out for its dual utility as a cholesterol-lowering agent and a potent apoptosis inducer in liver cancer models. This guide translates literature-backed workflows and troubleshooting strategies into practical, reproducible research outcomes.

• PTT and CD47 Blockade Synergize via ECM Remodeling in OSCC

  2026-05-18

  This study demonstrates that combining photothermal therapy (PTT) with CD47 blockade in oral squamous cell carcinoma (OSCC) enhances anti-tumor immunity by promoting calreticulin exposure and remodeling the tumor extracellular matrix. These mechanistic insights offer a new approach to overcoming immune evasion and stromal barriers in solid tumors.

• AO/PI Double Staining Kit: Practical Cell Viability Assay Gu

  2026-05-17

  The AO/PI Double Staining Kit enables rapid and reliable discrimination of viable, apoptotic, and necrotic cells using dual fluorescent staining. It is best applied in cell viability and cell death assays across diverse cell types, but should not be used for applications requiring single-dye specificity or in settings lacking fluorescence microscopy capabilities.

• Bufuralol Hydrochloride: Enabling Next-Gen Cardiovascular Mo

  2026-05-16

  Explore how Bufuralol hydrochloride, a non-selective β-adrenergic receptor antagonist with partial intrinsic sympathomimetic activity, is transforming cardiovascular pharmacology research. This article bridges mechanistic insight, advanced hiPSC-derived intestinal organoid models, and translational strategy—providing actionable guidance for researchers using APExBIO’s Bufuralol hydrochloride to accelerate β-adrenergic modulation studies and overcome key pharmacokinetic challenges.

• Ceftolozane Sulfate: PK/PD Modeling and Adaptive Resistance

  2026-05-15

  Explore how Ceftolozane sulfate enables advanced PK/PD modeling of adaptive resistance in Pseudomonas aeruginosa. This article offers a unique perspective on semi-mechanistic approaches, critical for researchers optimizing bactericidal assays.

• BCECF-AM (bis(acetoxymethyl)...) for Reliable Intracellular

  2026-05-15

  This article delivers scenario-driven guidance for optimizing intracellular pH measurement using BCECF-AM (bis(acetoxymethyl) 3,3'-(3',6'-bis(acetoxymethoxy)-5-((acetoxymethoxy)carbonyl)-3-oxo-3H-spiro[isobenzofuran-1,9'-xanthene]-2',7'-diyl)dipropanoate), focusing on SKU B5370. Researchers will find actionable protocols, troubleshooting advice, and evidence-based vendor comparisons, empowering reproducible and sensitive pH assays in diverse cell types.

• Diclofenac as a Non-Selective COX Inhibitor in Organoid PK A

  2026-05-14

  Diclofenac, a gold-standard non-selective COX inhibitor, is redefining inflammation and drug metabolism research within human iPSC-derived intestinal organoid systems. This article delivers protocol-centric insights, troubleshooting tactics, and evidence-based optimization for harnessing Diclofenac in advanced pharmacokinetic and pain signaling studies.

• Perifosine (KRX-0401): Deep Mechanistic Insights for Cancer

  2026-05-14

  Explore how Perifosine (KRX-0401) enables advanced apoptosis research by directly targeting the Akt/mTOR pathway. This article delivers a distinctive, mechanism-driven analysis and protocol guidance for optimizing cancer and neurological assays.

• O-GlcNAcylation Regulates Ferroptosis and Syncytialization i

  2026-05-13

  This study reveals that O-GlcNAc modification stabilizes HUWE1, promoting ubiquitination-mediated degradation of TfR1, which in turn limits ferroptosis and supports trophoblast syncytialization in preeclampsia. The findings identify the O-GlcNAc–HUWE1–TfR1 axis as a mechanistic regulator of placental pathology and a potential therapeutic target for PE.

• Sulfo-NHS-LC-Biotin: Technical Guide for Protein Biotinylati

  2026-05-13

  Sulfo-NHS-LC-Biotin provides a reliable, water-soluble reagent for covalent biotinylation of primary amines, especially on cell surface proteins. It is suitable for applications requiring selective, irreversible labeling in aqueous conditions and is not recommended for intracellular or reversible biotinylation workflows.

• CHIR-99021 in 3D Mesodermal Organoids: Advanced Assay Insigh

  2026-05-12

  Discover how CHIR-99021 (CT99021) unlocks new strategies for 3D organoid modeling and spatial cell fate control. This in-depth analysis bridges GSK-3 inhibition, Wnt/β-catenin signaling, and practical assay design in stem cell research.

• BODIPY 581/591 C11: Ratiometric Probe for Lipid Peroxidation

  2026-05-12

  BODIPY 581/591 C11 stands out as a highly sensitive ratiometric fluorescent probe for quantitative lipid peroxidation detection in live-cell and membrane models. Its unique red-to-green emission shift enables robust oxidative stress measurement and precise antioxidant capacity evaluation, setting the benchmark for reliable, real-time analysis in biomedical research.

• CXCR4-Targeted Imaging and Therapy in Lymphoma: Study Advanc

  2026-05-11

  This review details recent advances in CXCR4-targeted imaging ligands and therapeutic antagonists for lymphoma. By integrating molecular imaging with precision therapy, the study highlights how CXCR4 overexpression drives tumor progression and resistance, underlining the clinical potential of CXCR4-targeted strategies.

• 2,5-di-tert-butylbenzene-1,4-diol: Redefining SERCA Modulati

  2026-05-11

  This article delivers a thought-leadership perspective on leveraging 2,5-di-tert-butylbenzene-1,4-diol (BHQ) as a strategic tool for dissecting calcium signaling and optimizing hematopoietic stem cell (HSC) mobilization. Integrating recent mechanistic insights, experimental validation, and translational strategies, we illuminate how APExBIO’s BHQ uniquely empowers researchers to drive innovation in regenerative medicine. The discussion bridges foundational rationale, competitive landscape, and protocol guidance, and positions this work as a next-step evolution beyond typical product literature.

• Tofacitinib (CP-690550): Advanced Immune Modulation Protocol

  2026-05-10

  Tofacitinib (CP-690550) enables precise inhibition of JAK1/JAK3 signaling, offering unique control over cytokine-driven inflammation and mitochondrial repair in immune cell assays. This article translates breakthrough findings into actionable workflows, troubleshooting guidance, and highlights APExBIO’s role as a trusted supplier.

455 records 18/31 page Previous Next First page 上5页 1617181920 下5页 Last page